JDD Webinars

Differentiating Approach to Acne Therapy: Women Vs. Men

By October 14, 2020April 22nd, 2021No Comments

Featured Article

Differentiating Approach to Acne Therapy: Women vs. Men

Join Drs. Leon H. Kircik, MD and Julie Harper, MD as they discuss Acne severity and grade (comedonal, papulopustular, mixed, nodular), skin type, presence of acne scarring and postinflammatory hyperpigmentation, menstrual cycle history (in women), and more, as well as the factors influencing treatment with classes of topical agents.

Acne vulgaris is a chronic inflammatory dermatologic disease affecting an estimated 80% of the population at some point in their life; 85% of adolescents and young adult s may experience acne and prevalent in adults with more adult women being afflicted than adult men, raising the possibility that gender difference in skin may influence the pathogenesis of acne and treatment response.
Dermatologists indicate late-onset or adult -onset acne is becoming increasingly common in women in their 20s to 50s and research shows a large number of women over age 25 have acne and the prevalence of acne remains constant until age 44 at which time there is a decrease in incidence.

FACULTY


Leon H. Kircik, MD
Clinical Professor of Dermatology
Indiana University School of Medicine
Mount Sinai Medical Center, New York, NY
Physicians Skin Care, PLLC
Louisville, KY


Julie C. Harper, MD
Clinical Associate Professor of Dermatology
University of Alabama-Birmingham
Birmingham, Alabama

Watch Now

You May Also Like

Journal of Drugs in Dermatology JDD Article About 1% Colloidal Oatmeal Cream/Baby Wash Regimen Improved Atopic Dermatitis in Pediatric Patients From First Use

1% Colloidal Oatmeal Cream/Baby Wash Regimen Improved Atopic Dermatitis in Pediatric Patients From First Use

| Featured Articles, Latest News, Pediatrics, The Latest | No Comments
A simple 1% colloidal oatmeal regimen cut itch and improved eczema scores within days in toddlers A small open‑label study in children aged 3-72 months tested a twice‑daily 1% colloidal…
Journal of Drugs in Dermatology JDD Article About Examining an Antioxidant Biostimulating Treatment for Dark, Postinflammatory Hyperpigmentation-Prone Skin. Concentrates on skin of color

Examining an Antioxidant Biostimulating Treatment for Dark, Postinflammatory Hyperpigmentation-Prone Skin

| Dyspigmentation, Featured Articles, Latest News, Skin of Color, The Latest | No Comments
A multi-acid, antioxidant delivery approach that promises boost in radiance and texture without PIH.  Worth a look for patients with FST V–VI Facial rejuvenation that's both effective and safe in…
Journal of Drugs in Dermatology JDD Article About Refractory Pruritus Secondary to Linear IgA Bullous Dermatosis Treated Successfully With Nemolizumab: A Case Report

In Memoriam: Ronald Moy MD (1957-2025)

| Case Reports, Featured Articles, Latest News, Medical Derm, The Latest | No Comments
Honoring The Life of a Giant in Dermatologic Surgery We are all mourning the untimely passing of our esteemed colleague and friend, Dr Ron Moy, in July 2025. Dr Moy…

Leave a Reply